DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS
申请人:OncoArendi Therapeutics Sp. z o.o.
公开号:US20140309240A1
公开(公告)日:2014-10-16
The invention provides novel, water-soluble 2-aminoimidazoline derivatives having general Formula (I) as well as some precursors of Formula (I), which are very potent inducers of G2/M cell cycle arrest. In treated tumor cells, compounds of Formula (I) give gene expression profile distinct from known antimitotic agents. The invention also provides methods for preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirably high levels of cell proliferation. The compounds of the invention are also expected to have utility as research tools.
该发明提供了具有一般式(I)的新型水溶性2-氨基咪唑啉衍生物以及一些一般式(I)的前体,这些衍生物是非常有效的G2/M细胞周期阻滞诱导剂。在处理的肿瘤细胞中,一般式(I)的化合物提供了与已知抗有丝分裂剂不同的基因表达谱。该发明还提供了制备这些化合物的方法,以及使用这些化合物治疗癌症或其他由细胞过度增殖导致的哺乳动物疾病的方法。该发明的化合物还预计具有作为研究工具的用途。